Voyager Therapeutics, Inc. Made Big Gain

Voyager Therapeutics, Inc. (VYGR:NASDAQ) jumped higher at $3.87, a gain of 48.3%. On Tue, Oct 05, 2021, VYGR:NASDAQ hit a New 2-Week Low of $2.47. The stock got featured on our News Catalysts scanner on Wed, Oct 06, 2021 at 02:33 PM in the 'AGREEMENT' category. From Tue, Sep 21, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Apr 26, 2021 at $5.97 with a volume of 7M+.
About Voyager Therapeutics, Inc. (VYGR:NASDAQ)
Voyager Therapeutics Inc, in collaboration with Genzyme, conducts research and development work to develop therapies for the treatment of central nervous system disorders. It targets diseases such as Parkinson's, Alzheimer's Huntington's.
Top 10 Gainers:
- Xenon Pharmaceuticals Inc. (XENE:NASDAQ), 105.32%
- PPHP (PPHP:NASDAQ), 100%
- WINV (WINV:NASDAQ), 100%
- APMI (APMI:NASDAQ), 100%
- Elmira Savings Bank (ESBK:NASDAQ), 67.78%
- GROM (GROM:NASDAQ), 52.29%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 48.28%
- LGHL (LGHL:NASDAQ), 46%
- BTBT (BTBT:NASDAQ), 39.03%
- ZETA (ZETA:NYSE), 29.82%